Tower Research Capital LLC (TRC) - IMMUNOCORE HLDGS PLC ownership

IMMUNOCORE HLDGS PLC's ticker is IMCR and the CUSIP is 45258D105. A total of 127 filers reported holding IMMUNOCORE HLDGS PLC in Q3 2023. The put-call ratio across all filers is 0.01 and the average weighting 0.6%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of IMMUNOCORE HLDGS PLC
ValueSharesWeighting
Q3 2023$175,837
+14.2%
3,388
+31.9%
0.01%
+20.0%
Q2 2023$153,977
+48626.9%
2,568
-59.8%
0.01%
-50.0%
Q1 2023$316
+146.9%
6,388
+185.1%
0.01%
+100.0%
Q4 2022$128
-99.9%
2,241
-28.7%
0.01%
+150.0%
Q3 2022$148,000
+1245.5%
3,145
+1003.5%
0.00%
Q2 2022$11,000
+1000.0%
285
+1400.0%
0.00%
Q4 2021$1,000190.00%
Other shareholders
IMMUNOCORE HLDGS PLC shareholders Q3 2023
NameSharesValueWeighting ↓
Bill & Melinda Gates Foundation 576,923$28,523,07325.19%
Velan Capital Investment Management LP 200,000$9,888,0008.43%
RTW INVESTMENTS, LP 5,649,943$279,333,1825.82%
Paradigm Biocapital Advisors LP 1,126,256$55,682,0975.28%
Rock Springs Capital Management LP 3,001,662$148,402,1693.54%
Logos Global Management LP 500,000$24,720,0003.54%
TANG CAPITAL MANAGEMENT LLC 405,600$20,052,8642.99%
GREAT POINT PARTNERS LLC 255,367$12,625,3442.48%
COWEN AND COMPANY, LLC 405,174$20,031,8022.35%
Eschler Asset Management LLP 60,000$2,966,4002.34%
View complete list of IMMUNOCORE HLDGS PLC shareholders